These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 24953434)
21. Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats. Ross JT; Corrigall WA; Heidbreder CA; LeSage MG Eur J Pharmacol; 2007 Mar; 559(2-3):173-9. PubMed ID: 17303116 [TBL] [Abstract][Full Text] [Related]
22. Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration. Liu X; Jernigan C Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):146-53. PubMed ID: 20965223 [TBL] [Abstract][Full Text] [Related]
23. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine. Grottick AJ; Corrigall WA; Higgins GA Psychopharmacology (Berl); 2001 Sep; 157(3):292-8. PubMed ID: 11605085 [TBL] [Abstract][Full Text] [Related]
24. D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response. Levin ED; Slade S; Wells C; Petro A; Rose JE Pharmacol Biochem Behav; 2011 Apr; 98(2):210-4. PubMed ID: 21192967 [TBL] [Abstract][Full Text] [Related]
25. Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction. Forget B; Wertheim C; Mascia P; Pushparaj A; Goldberg SR; Le Foll B Neuropsychopharmacology; 2010 Jul; 35(8):1751-60. PubMed ID: 20357760 [TBL] [Abstract][Full Text] [Related]
26. Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats. Hall BJ; Wells C; Allenby C; Lin MY; Hao I; Marshall L; Rose JE; Levin ED Pharmacol Biochem Behav; 2014 May; 120():103-8. PubMed ID: 24560911 [TBL] [Abstract][Full Text] [Related]
27. Varenicline impairs extinction and enhances reinstatement across repeated cycles of nicotine self-administration in rats. Macnamara CL; Holmes NM; Westbrook RF; Clemens KJ Neuropharmacology; 2016 Jun; 105():463-470. PubMed ID: 26907808 [TBL] [Abstract][Full Text] [Related]
28. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754 [TBL] [Abstract][Full Text] [Related]
29. Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline. Schassburger RL; Levin ME; Weaver MT; Palmatier MI; Caggiula AR; Donny EC; Sved AF Psychopharmacology (Berl); 2015 Mar; 232(5):975-83. PubMed ID: 25209677 [TBL] [Abstract][Full Text] [Related]
30. Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats. Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT Psychopharmacology (Berl); 2006 Mar; 184(3-4):426-34. PubMed ID: 16220336 [TBL] [Abstract][Full Text] [Related]
31. Conditioned reinforcement in rats established with self-administered nicotine and enhanced by noncontingent nicotine. Palmatier MI; Liu X; Matteson GL; Donny EC; Caggiula AR; Sved AF Psychopharmacology (Berl); 2007 Dec; 195(2):235-43. PubMed ID: 17676401 [TBL] [Abstract][Full Text] [Related]
32. Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose. Liu X; Caggiula AR; Palmatier MI; Donny EC; Sved AF Psychopharmacology (Berl); 2008 Feb; 196(3):365-75. PubMed ID: 17932656 [TBL] [Abstract][Full Text] [Related]
34. Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking. Sabioni P; Di Ciano P; Le Foll B Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():149-54. PubMed ID: 26279138 [TBL] [Abstract][Full Text] [Related]
35. An operant ethanol self-administration paradigm that discriminates between appetitive and consummatory behaviors reveals distinct behavioral phenotypes in commonly used rat strains. Patwell R; Yang H; Pandey SC; Glover EJ Neuropharmacology; 2021 Dec; 201():108836. PubMed ID: 34648771 [TBL] [Abstract][Full Text] [Related]
36. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats. Hayes DJ; Mosher TM; Greenshaw AJ Behav Brain Res; 2009 Feb; 197(2):323-30. PubMed ID: 18805442 [TBL] [Abstract][Full Text] [Related]
37. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine. Tronci V; Vronskaya S; Montgomery N; Mura D; Balfour DJ Psychopharmacology (Berl); 2010 Jul; 211(1):33-42. PubMed ID: 20422403 [TBL] [Abstract][Full Text] [Related]
38. Patterns of responding differentiate intravenous nicotine self-administration from responding for a visual stimulus in C57BL/6J mice. Contet C; Whisler KN; Jarrell H; Kenny PJ; Markou A Psychopharmacology (Berl); 2010 Oct; 212(3):283-99. PubMed ID: 20668842 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles. Higgins GA; Silenieks LB; Lau W; de Lannoy IA; Lee DK; Izhakova J; Coen K; Le AD; Fletcher PJ Psychopharmacology (Berl); 2013 Apr; 226(3):475-90. PubMed ID: 23184281 [TBL] [Abstract][Full Text] [Related]